NCT04385823View on ClinicalTrials.gov

Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

May 4, 2020

Study Completion Date

May 4, 2020

Conditions
Respiratory Syndrome, Acute, SevereHypoxic Respiratory FailureViral Pneumonia
Interventions
DEVICE

patients receiving nasal high flow

patients admitted to the ICU for Covid-19-related acute hypoxemic respiratory failure treated with nasal high flow

Trial Locations (1)

92700

Hôpital Louis Mourier, Assistance Publique - Hôpitaux de Paris, Colombes

All Listed Sponsors
lead

Hôpital Louis Mourier

OTHER

NCT04385823 - Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure | Biotech Hunter | Biotech Hunter